Upgrade to SI Premium - Free Trial

Teladoc (TDOC) PT Lowered to $120 at Goldman Sachs, Keeps 'Buy'

February 23, 2022 7:23 AM
Goldman Sachs analyst Cindy Motz lowered the price target on Teladoc (NYSE: TDOC) to $120.00 (from $121.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Analyst PT Change

Next Articles